WINTON GROUP Ltd Has $898,000 Holdings in Encompass Health Co. (NYSE:EHC)

WINTON GROUP Ltd decreased its position in Encompass Health Co. (NYSE:EHC) by 33.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,729 shares of the company’s stock after selling 4,804 shares during the period. WINTON GROUP Ltd’s holdings in Encompass Health were worth $898,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC increased its stake in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health during the 3rd quarter valued at $68,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Down 0.4 %

Shares of EHC stock opened at $100.75 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a market capitalization of $10.15 billion, a price-to-earnings ratio of 22.59, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 52-week low of $78.53 and a 52-week high of $104.55. The company has a 50-day simple moving average of $98.67 and a two-hundred day simple moving average of $97.42.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Analysts Set New Price Targets

Several research firms have weighed in on EHC. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp increased their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. Finally, Barclays boosted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus target price of $107.67.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.